loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

List of Certificates of Suitability (CEPs) for Raloxifene Hydrochloride Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DR. REDDY'S LABORATORIES LIMITED Hyderabad IN (1)

02 APITORIA PHARMA PRIVATE LIMITED Hyderabad IN (2)

03 APOTEX PHARMACHEM INDIA PVT. LTD Bangalore IN (1)

04 AURORE LIFE SCIENCES PRIVATE LIMITED Hyderabad IN (1)

05 EXCELLA GMBH Feucht DE (1)

06 Erregierre S.p.A. San Paolo D'Argon IT (1)

07 GLOCHEM INDUSTRIES PRIVATE LIMITED Hyderabad IN (2)

08 HETERO DRUGS LIMITED Hyderabad IN (1)

09 KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR (1)

10 OLON S.P.A. Rodano IT (1)

filter

01 Raloxifene hydrochloride (10)

02 Raloxifene hydrochloride, LAXAI (1)

03 Raloxifene hydrochloride, Modified process (1)

filter

01 Canada (1)

02 Germany (1)

03 India (7)

04 Italy (2)

05 South Korea (1)

filter

01 Expired (1)

02 Valid (10)

03 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2017-097 - Rev 00
Valid
Chemical
2019-02-06
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CEP 2024-069 - Rev 00
Valid
Chemical
2024-04-24
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CEP 2012-016 - Rev 02
Valid
Chemical
2024-01-05
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CEP 2022-165 - Rev 00
Valid
Chemical
2024-04-22
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
R1-CEP 2010-205 - Rev 00
Valid
Chemical
2017-09-06
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CEP 2023-123 - Rev 00
Valid
Chemical
2023-11-29
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
R1-CEP 2010-227 - Rev 01
Valid
Chemical
2019-10-15
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
R1-CEP 2011-349 - Rev 00
Valid
Chemical
2020-11-30
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
R1-CEP 2015-171 - Rev 00
Valid
Chemical
2022-04-08
2375
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 82640-04-8 / Raloxifene Hydrochloride API manufacturers, exporters & distributors?

Raloxifene Hydrochloride manufacturers, exporters & distributors 1

40

PharmaCompass offers a list of Raloxifene Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Raloxifene Hydrochloride manufacturer or Raloxifene Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Raloxifene Hydrochloride manufacturer or Raloxifene Hydrochloride supplier.

PharmaCompass also assists you with knowing the Raloxifene Hydrochloride API Price utilized in the formulation of products. Raloxifene Hydrochloride API Price is not always fixed or binding as the Raloxifene Hydrochloride Price is obtained through a variety of data sources. The Raloxifene Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Raloxifene Hydrochloride

Synonyms

82640-04-8, Raloxifene hcl, Evista, Keoxifene hydrochloride, Keoxifene, Optruma

Cas Number

82640-04-8

Unique Ingredient Identifier (UNII)

4F86W47BR6

About Raloxifene Hydrochloride

A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.

Raloxifene Hydrochloride Manufacturers

A Raloxifene Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raloxifene Hydrochloride, including repackagers and relabelers. The FDA regulates Raloxifene Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ralox